Medical Design & Manufacturing (MD&M)

Minnesota Medtech Week is an unprecedented combination of the two most important medical device and health technology events in the region, which have a combined 50-year history in the Twin Cities. The event will gather all key players in the industry – from engineers and product developers to physicians, hospital administrators and executives. Concurrent conference tracks take deep dives into two of the most important industry topics—market access and patient engagement.

Cook Medical has received premarket approval from the U.S. Food and Drug Administration (FDA) for its lower-profile Zenith Alpha Thoracic endovascular graft.

For the first time, European Society of Cardiology (ESC) guidelines give the highest degree of recommendation for the radial over the femoral approach for coronary angiography and percutaneous coronary intervention (PCI) in patients with acute coronary syndromes (ACS). The ACS without persistent ST-segment elevation (NSTE-ACS) guidelines, drafted by an international multidisciplinary task force, are published online in European Heart Journal and on the ESC website.

St. Jude Medical Inc. announced European CE Mark approval for the 27mm and 29mm Portico transcatheter aortic valve replacement (TAVR) system. The approval follows previous approvals of the 23mm and 25mm Portico valves, allowing St. Jude Medical to offer physicians an expanded range of fully repositionable, retrievable TAVR valve sizes. The Portico valve accommodates a patient’s native anatomy with diameters ranging from 19 to 27 mm.

SynCardia Systems initiated a Class I recall of the Freedom Driver Systems used with the company’s temporary Total Artificial Heart (TAH-t) on Aug. 6, 2015. The recall focused on a specific part of the Freedom Driver drive mechanism that the company said may fail and cause the device to stop pumping.

International Academy of Cardiology Scientific Sessions / World Congress on Heart Disease

The Congress will provide the opportunity for a comprehensive overview of the latest research developments in cardiovascular medicine, primarily in the areas of Molecular and Cellular Cardiology, Genetics of Heart Disease, Cardiac Imaging, Coronary Artery Disease, Peripheral Arterial Disease, Interventional Cardiology, Lipoprotein Disorders, Hypertension, Metabolic Syndrome, Heart Failure, Valvular Heart Disease, Diseases of the Aorta, Cardiac Arrhythmias and Electrophysiology, Implantable Cardiac Pacemakers and Cardioverter-Defibrillators, Sudden Cardiac Death, Pediatric Cardiology, Congen


MedLumics has announced the completion of a successful single-case pre-clinical feasibility study of its optical coherence tomography (OCT) technology in the catheter ablation treatment of atrial fibrillation (AF).


Subscribe Now